The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems. 

CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.  

At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries.

Clinton Health Access Initiative India Private Limited (CIPL) is a private entity, majority-owned by the Clinton Health Access Initiative (CHAI), a US-based non-profit organization. CIPL operates independently and exclusively provides export-based services, contributing to CHAI’s goals of improving healthcare access, delivery, and outcomes in underserved populations. CIPL serves as a Global Shared Service (GSS) or Global Capability Center (GCC) harnessing technical expertise and innovative solutions to address global health challenges.

CIPL is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CIPL values diversity, inclusion and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.

Program Overview

The CHAI Global Markets Team (GMT) supports CHAI’s diverse programs in achieving sustainable access to best-in-class drugs and diagnostic tests. GMT is responsible for leading, designing, negotiating, and supporting the effective implementation of market shaping interventions and access programs that increase the uptake of critical health commodities in LMICs. Market-shaping interventions range from traditional policy-led and grant-financed initiatives such as pooled procurement, coordinated ordering, and strategic demand forecasting to more innovative mechanisms such as volume guarantees (VGs), advance market commitments (AMCs), and working capital facilities. Examples of programs developed and led by GMT include the following: 

• CHAI and The Hepatitis Fund announce pricing breakthrough to reduce cost of viral hepatitis treatment by over 90 percent 
• New agreement secures historic US$1 price for HIV self-test 
• Global partnership to make available 120M affordable, quality COVID-19 rapid tests for low- and middle-income countries 
• Price reduction agreement for contraceptive implants increased distribution by >50% and will save more than US$300M 

The GMT collaborates with internal and external stakeholders on both the supply- and demand-sides of the market to assess the potential public-health impact of proposed market-shaping interventions. The GMT also takes the lead within CHAI in developing access programs and managing relationships with global and regional life science companies.

Position Overview

CHAI pioneered and developed the practice of market shaping interventions for public health in LMICs.   The Senior Director GMT builds relationships with CHAI’s country and program leadership teams, working in partnerships to develop, provide and lead and /or support the execution of the strategies and programs to sustain CHAI’s leadership role in market shaping globally and in country, across a broad portfolio of health products and services.   

The Senior Director GMT demonstrates an unwavering commitment to advancing CHAI’s mission and consistently embodies CHAI’s Values in their interactions with staff and partners. She/he is a highly respected individual who provides inspiration and thought leadership to peers and team members. The Senior Director GMT is a member of CHAI GMT’s Senior Leadership Team and reports to the VP and head of GMT. 

The Senior Director is responsible for leading and managing a high-performing, talented and diverse group of staff based in the US, India, Africa, and Europe, and effectively working cross-functionally, to deliver on both GMT goals and relevant market-shaping program goals.  She/he will have a proven track record of actively enlisting and developing and mentoring high potential talent on their teams.  The Senior Director has budgetary responsibility for his/her team within GMT and may also take the lead in managing GMT grants and/or co-managing some large program grants. 

The Senior Director will be responsible for working alongside the VP GMT to define, build and maintain a “fit for purpose” structure for GMT, including mobilizing resources to support GMT’s “fit for purpose” model, including strengthening GMT’s integrated One Team approach with program and with country teams, as some market shaping becomes more regionalized/localized. 

The Senior Director will be a senior negotiator within GMT and will be responsible for leading negotiations on key market-shaping interventions and mentoring staff as it relates to supplier negotiations. He/she will be responsible for engaging actively in defining program strategies and leading the execution of the market-shaping aspects of those strategies. He/she will also be responsible for creating and managing opportunities for CHAI’s sector influence, e.g. at strategic global for a, etc. to enhance CHAI's leading position as a global market shaper, as well as support CHAI’s market-shaping goals and catalyze broader transformational change. 

As a senior leader within the organization, the Senior Director will be actively engaged in business development, supporting major grant submissions made by program teams, building long term collaborative relationships with peers in funding organizations, and developing innovative programs that attract new donors to CHAI.   

The Senior Director must demonstrate domain experience and expertise in the following areas of his scope: 

• negotiating product deals with biopharmaceutical and diagnostic companies  
• biopharmaceutical and diagnostic industry operations, as well as the development, manufacturing and commercialization of drugs and diagnostics 
• aligning various global health partners, from governments to donors, procurers, and guarantors, in support of deals  
• market analysis and market research 
• country and global regulatory systems for the approval of new drugs and diagnostics 
• global public health funding and policy setting  
• proven ability to manage the global health political ecosystem  
• multilateral funded health care programs in areas such as Malaria, TB, HIV, and Nutrition  
• working effectively across a complex organizational matrix, including varying countries  
• support CHAI Country teams to improve access to health commodities.

• 15+ years of progressive experience in the life sciences sector including pharmaceutical and diagnostic products companies and/or related experience  
• 5+ years of experience in a senior leadership and supervisory role, with demonstrated ability to recruit, manage, evaluate, and develop staff and contribute to the fostering of a diverse and results-oriented team. 
• In depth knowledge of pharmaceutical and diagnostic company business models, specifically in the emerging markets  
• Exceptional product and policy negotiation skills, with the ability to achieve large scale impact 
• Exceptional strategic development skills with the ability to identify and pursue high-impact strategies in complex, uncertain and evolving environments 
• Exceptional analytical (quantitative and qualitative) and communication (written and oral) skills, including the ability to communicative effectively with people of varied professional and cultural backgrounds 
• Exceptional ability to build innovative international partnerships with highly diverse partners 
• Entrepreneurial mindset, including ability to work independently, self-motivate, and propose and implement new initiatives 
• Ability to be effective in high-pressure situations, handle multiple tasks simultaneously, and set priorities 
• Strong desire to work in a fast-paced, limited-structure, high-pressure, multicultural environment 
• Detail-oriented with strong organization skills 
• Proven project management skills, based on several years of experience in strategic, operational, and financial management of complex, multi-stakeholder projects 
• Exceptional interpersonal and communication skills in English (written and verbal), with the ability to develop and maintain trusted relationships internally and externally. 
• Experience managing high performing teams and mentoring team members.
• Experience managing budgets and revenue forecasts.  
• Ability to travel in CHAI’s regions of operation, and work across multiple time zones, as necessary. 

Advantages 

• Experience working remotely with a decentralized team. 
• Experience working in organization with diversified operations and large annual budget.
• Experience in healthcare, international development, life sciences (e.g., vaccines, biotechnology, pharmaceuticals). 
• Experience working in or supporting low- and middle-income countries. 
• Professional fluency in additional languages, such as French, Spanish, Hindi, or Swahili. 

#jobreference4 #region2